The receptors, proteins, and signal pathways are intricate and not well understood, though
Diabetes 67(Supplement 1):522 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Cell J 24:603611
Table 3 presents a subgroup analysis of baseline demographics in psychiatric outcomes associated with the use of GLP-1 RA
Int J Mol Sci 20:1475
This might include the counteraction of various arrhythmias [66,67,68,69,70,71,72,73,74,75,76,77,78,80,81,82,102,103,105,106,122,123,154] and thromboses, even blood pressure disturbances (intracranial (superior sagittal sinus), portal and caval hypertension, and aortal hypotension [66,71,72,73,74,75,76,77,78,79,80,81,82], or hypertension (hyperkalemia, NOS-blockade) [67,105] that were attenuated/eliminated peripherally and centrally))